Surgery Partners, Inc. (SGRY) financial statements and ratios from SEC XBRL: revenue $3.4B (TTM), net margin -2.4%, revenue growth 6.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $3.31B |
| Revenue (TTM) | $3.4B |
| Net Margin | -2.4% |
| Operating Margin (TTM) | 11.4% |
| Revenue Growth (YoY) | 6.2% |
| EPS Growth (YoY) | -54.1% |
| FCF Growth (YoY) | -6.7% |
| EV / EBITDA | 3.3 |
| Price / Book | 0.59 |
| Price / Sales | 0.56 |
| FCF Yield | 7.1% |
| Altman Z-Score | 0.72 (distress) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
SGRY overview · SGRY earnings · SGRY KPIs · SGRY documents · SGRY ownership · SGRY peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.